VeriMombenzophenone-4 hamilelikte güvenli mi?
The SCCS (final opinion adopted 27 Mar 2024) concluded benzophenone‑4 is safe as a cosmetic UV filter up to 5% while noting concerns about potential endocrine‑disrupting properties; there is no harmonised CLP reproductive classification (H361/H360) for BP‑4. CIR’s amended benzophenones review compiles toxicology and biomonitoring data but does not identify BP‑4 as a confirmed reproductive teratogen. These authoritative assessments support hazard = 0, but documented in vitro/alternate endocrine signals reported for benzophenone family members justify a limited mechanistic concern (m=1). Dermal absorption is measurable but relatively low (BP‑4 is water‑soluble with low log Kow ~0.37); SCCS exposure assessment underlies the 5% limit, so exposure = 1 (low but measurable).
Pregnancy-safe products containing benzophenone-4
Related ingredients
Frequently asked questions
- benzophenone-4 hamilelikte güvenli mi?
- The SCCS (final opinion adopted 27 Mar 2024) concluded benzophenone‑4 is safe as a cosmetic UV filter up to 5% while noting concerns about potential endocrine‑disrupting properties; there is no harmonised CLP reproductive classification (H361/H360) for BP‑4. CIR’s amended benzophenones review compiles toxicology and biomonitoring data but does not identify BP‑4 as a confirmed reproductive teratogen. These authoritative assessments support hazard = 0, but documented in vitro/alternate endocrine signals reported for benzophenone family members justify a limited mechanistic concern (m=1). Dermal absorption is measurable but relatively low (BP‑4 is water‑soluble with low log Kow ~0.37); SCCS exposure assessment underlies the 5% limit, so exposure = 1 (low but measurable).
- benzophenone-4 emzirirken güvenli mi?
- No authoritative agency (SCCS/CIR/ECHA) lists BP‑4 as a reproductive or lactation hazard; biomonitoring literature for benzophenones documents maternal exposure and detection in biological matrices for some benzophenones (most data are for BP‑3), but direct evidence of adverse effects in breastfeeding infants from BP‑4 is lacking. Mechanistic signals for endocrine activity in the benzophenone class justify a low theoretical mechanism score (m=1). Expected transfer to breast milk appears low/limited for BP‑4 specifically, so exposure = 1 (low but measurable).
- benzophenone-4 bebek cildi için güvenli mi?
- There is no high‑level evidence (harmonised CLP H361/H360 or human developmental toxicity) implicating BP‑4 as a reproductive/teratogenic hazard; therefore hazard = 0. Mechanistic concern remains theoretical (m=1) based on class signals. Because infant skin has higher permeability and the ingredient has measurable dermal absorption in adults, exposure is increased by +1 for infants (adult e=1 → baby e=2).
- VeriMom benzophenone-4 nasıl puanlıyor?
- VeriMom benzophenone-4'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 87/100 (düşük risk) olarak puanlar.
- Hamilelikte benzophenone-4 yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.